Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding ...

Advancements in AI mean that people can create software just by describing it. Consider this your vibe coding primer.

Recursion Pharmaceuticals RXRX shares have gained 5.5% in a month. The stock gained momentum after the company announced the ...